Top compounds associated with response to RP11-729L2.2


Feature Type Standardized
Nominal ANOVA
mRNA SR1001 CTRPv2 pan-cancer AAC 0.08 0.06
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.081 0.06
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.072 0.06
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.067 0.06
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.094 0.06
mRNA quizartinib CTRPv2 pan-cancer AAC 0.076 0.06
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.13 0.06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.06
mRNA procarbazine CTRPv2 pan-cancer AAC -0.08 0.07
Download CSV